Navigation Links
Early Birds Save Up to $600 on Asian Biotech and Pharmaceutical Conferences
Date:7/12/2012

FARMINGTON, Conn., July 12, 2012 /PRNewswire-iReach/ -- Successful businesses stay connected to the biotech market, network, and forge new business relationships with industry leaders at global biotech conferences with help from Global Information Inc. Attendees go to learn about new innovations, how to implement effective strategies, and tactics for minimizing costs and risks while overcoming regulatory and technological hurdles.

(Photo: http://photos.prnewswire.com/prnh/20120712/CG39694)

Global Information announces limited early bird registrations for three important biotech and pharmaceutical conferences in Shanghai and Singapore.

Bio World China 2012

November 5 – 7, 2012 – Shanghai, China

Facilitate innovation and manufacturing of affordable and high quality vaccine and biopharmaceutical drugs in China. This conference is China's largest biopharmaceutical industry gathering of decision makers across C-level management in the realms of biologics, biosimilars, vaccines and blood/plasma products. Bio World China 2012 will feature over 50 CEOs from China's major biopharmaceutical companies, 300+ senior decision makers from all major biopharmaceutical players from China and globally, 50+ case studies ranging from investments, cell culture engineering, blood product developments, vaccines industry trends and R&D updates, stem cell technologies and biomanufacturing best practices. Additionally, ample networking time ensures quality face time to forge lasting business relationships.

Save $600 by registering before July 31! More information available at http://www.giiconference.com/ima236697-2012/

Biologic Manufacturing China 2012

October 17 – 18, 2012 – Shanghai, China

The face of the biopharmaceutical sector is changing substantially, with rapid developments in both developed countries and emerging markets. By 2016, biologic therapeutics are forecast to account for 23% of the global medicine market creating a market of USD 158 billion.

Compared to chemical drug manufacturing, biologic manufacturers are challenged with more complex processes and stringent regulatory requirements. Better planning, more investment and more sophisticated knowledge of the technologies are required in both early development and scale up projects to achieve desired results. Biologic Manufacturing China 2012 has all the answers companies are looking for whether in early stage development, maturing into scale up manufacturing, or a mature international organization.

Register before August 10 and save $400! More information is available at http://www.giiconference.com/iqpc243588-2012/

2nd Annual Clinical Trial Supply Asia

October 15 – 16, 2012 – Singapore

With the surge in the clinical services market and an increase in demand for clinical logistics in Asia, three major challenges confront the clinical trial supply in Asia this year: 1) Regulatory affairs; 2) Cost and quality; and 3) Temperature controlled distribution. The 2nd Annual Clinical Trial Supply Asia 2012 summit will cover these three topics and more. This event is Asia's leading high-level platform for clinical trial supply directors and clinical trial project managers from leading pharmaceutical companies, biopharmaceutical companies and CROs. Attendees will hear what industry leaders have to say about implementing effective clinical trial supply strategies in Asia to achieve successful on-time delivery and minimize costs and risks.

Save up to $640 by registering before August 10!  More information is available at http://www.giiconference.com/iqpc246344-2012/

About Global Information Inc. Global Information (GII) (http://www.giiresearch.com) is an information service company partnering with over 300 research companies around the world. Global Information has been in the business of distributing technical and market research for more than 25 years. Expanded from its original headquarters in Japan, Global Information now has offices in Korea, Taiwan, Singapore, Europe and the United States.

Media Contact: Jeremy Palaia Global Information, Inc., 1-860-674-8796, Press@gii.co.jp

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE Global Information, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Nearly 300 Medical Device, Healthcare Professionals Attend First National Conference on Value-driven Engineering
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Evergreen Healthcare Foundation Gala Raises Nearly $1.1 Million to Benefit Breast Health Center
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Islet Sciences Announces Exclusive License Agreement with Yale University to Commercialize an Early Beta Cell Destruction and Diabetes Diagnostic
6. Early Coronary Artery Healing Advantage of OrbusNeichs Combo Dual Therapy Stent™ Compared to the TAXUS® Stent Shown in Two Clinical Trial Subgroup Analyses
7. Varian Medical Systems to Showcase Radiosurgery Technology for Non-invasive Treatment of Early Stage Inoperable Lung Cancer
8. joimax® at the Early Summer Congresses: SpineWeek Amsterdam and DGNC Leipzig
9. Senate to Vote on Final FDA User Fee Bill As Early As Today
10. GenWay Biotech Appoints New Vice President of Custom/OEM
11. Amarantus BioSciences to Present at the New York Biotechnology Association (NYBA) 21st Annual Meeting on May 2nd, 2012
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 9, 2016 On ... Administration (FDA) met with its Arthritis Advisory ... biosimilar of Johnson & Johnson,s Remicade and ... approved in the U.S. The Biologics Prescribers ... groups - Alliance for Patient Access, American ...
(Date:2/9/2016)... Calif. , Feb. 9, 2016 /PRNewswire/ - Nevro ... company that is providing innovative evidence-based solutions for the ... release financial results for the fourth quarter and full ... 29, 2016. Company management will host a conference call ... Time) on Monday, February 29, 2016. www.nevro.com ...
(Date:2/9/2016)... 9, 2016  Sangamo BioSciences, Inc. (NASDAQ: ... today reported its fourth quarter and full year ... vivo therapeutic genome editing," said Edward Lanphier, ... finger nuclease (ZFN) technology leads the therapeutic genome ... competencies necessary to move our ground-breaking genome editing ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 09, 2016 , ... Ross A. Clevens, MD, ... to welcome a new addition to their growing practice. Beginning this month, Teresa ... nurse practitioner performing cosmetic procedures including injectables, fillers and laser treatments. ...
(Date:2/9/2016)... ... February 09, 2016 , ... Steven Douglas Associates is a ... Florida Event, an upscale fundraiser held in South Florida. The Inaugural What’s Your Taste ... This year the event will be held in a new, more causal format at ...
(Date:2/9/2016)... ... February 09, 2016 , ... ... production of its newest mobility device, the StandUp Walker. Made entirely in the ... in the last 50 years. , StandUp Walker’s novel patent-pending design offers 2-in-1 ...
(Date:2/9/2016)... Springs, FL (PRWEB) , ... February 09, 2016 ... ... leading innovative specialty pharmacies, announces today the continuation of the ‘Pay It Forward’ ... for each prescription referral received at our specialty pharmacy. , “Since our ...
(Date:2/9/2016)... ... February 09, 2016 , ... The Bon-Ton Stores, Inc. (NASDAQ: ... stores, announced it has raised $176,000 to benefit the Breast Cancer Research Foundation, ... at the University of Iowa, The Lynn Sage Cancer Research Foundation, and Masonic ...
Breaking Medicine News(10 mins):